Skip to main content
METabolic EXplorer logo

METabolic EXplorer — Investor Relations & Filings

Ticker · METEX ISIN · FR0004177046 LEI · 969500VI1GSBPGD9B460 PA Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2013-02-28 Regulatory Filings
Country FR France
Listing PA METEX

About METabolic EXplorer

https://www.metabolic-explorer.com/

METabolic EXplorer (METEX) is an industrial biotechnology company specializing in the development and industrialization of fermentation bioprocesses. The company produces functional ingredients and chemical intermediates from renewable, non-food raw materials, offering sustainable alternatives to petrochemical processes. Its portfolio is centered on three main product families: 1,3-propanediol (PDO) for cosmetics, liquid polymers, and textiles; butyric acid (BA) for animal nutrition and the flavors and fragrances market; and amino acids for animal feed. The company operates through its subsidiaries, METEX NØØVISTA, which manages the PDO and BA production, and METEX NØØVISTAGO, which focuses on amino acids and ingredients for animal nutrition.

Recent filings

Filing Released Lang Actions
Point d'étape sur l'implantation de METabolic EXplorer en Malaisie
Regulatory Filings Classification · 95% confidence The document is a press release dated February 28, 2013, detailing an update on discussions between METabolic EXplorer and Bio-XCell regarding the amendment of a contractual framework related to the construction and financing of a plant. It announces that a new update will be provided by March 15, 2013. This type of communication, which provides an update on ongoing business negotiations or project status without being a full financial report (like 10-K or IR) or a formal regulatory filing for a specific event (like a dividend or management change), fits best under the general category of Regulatory Filings (RNS) as a miscellaneous corporate announcement, or potentially a Legal Proceedings Report (LTR) if the contractual dispute was severe, but here it seems like a standard business update. Given the options, and since it's a general communication about business progress rather than a specific financial outcome or mandated disclosure form, RNS (Regulatory Filings / General Regulatory Announcements) is the most appropriate fallback category for this type of operational update announcement.
2013-02-28 French
Information financière du 4ème trimestre 2012
Earnings Release Classification · 98% confidence The document is titled "METabolic EXplorer: Information financière du 4ème trimestre 2012" and explicitly states that the company "publie aujourd'hui son information financière du 4 ème trimestre 2012." It provides key financial highlights (revenue for Q4 2012 and the full year 2012) in a brief format, including a summary table. This structure—a short announcement releasing period-specific financial data—is characteristic of an Earnings Release (ER). It is not a comprehensive report (like 10-K or IR) nor a full transcript (CT). Given the focus on quarterly financial results announcement, ER is the most appropriate classification. Q4 2012
2013-02-20 French
Bilan du contrat de liquidité
Transaction in Own Shares Classification · 95% confidence The document is titled "METabolic EXplorer : Bilan du contrat de liquidité" (Liquidity Contract Balance Sheet) and provides a year-end summary (as of December 31, 2012) of the assets held under a liquidity contract managed by CM-CIC Securities, comparing them to the previous semi-annual balance (June 30, 2012). This content specifically details the status of share repurchase agreements or market-making activities, which falls under the category of transactions involving the company's own shares (share buybacks or issuance). Therefore, the most appropriate classification is Transaction in Own Shares (POS). It is not a full financial report (10-K or IR), nor a general earnings release (ER).
2013-01-14 French
Réorganisation de l'entreprise : adaptation de la gouvernance
Board/Management Information Classification · 98% confidence The document is a press release dated January 10, 2013, announcing a reorganization of the company's governance structure. Specifically, it states that the prerogatives of the general management are consolidated under the CEO, and a new General Secretary role is established. This directly relates to changes in the company's senior management and board structure. According to the definitions, 'Board/Management Information (Code: MANG)' covers the 'Announcement of changes in the company's board of directors or senior management.' The document is short and serves as an announcement, not a comprehensive report.
2013-01-10 French
Company reorganisation: governance adjustment
Board/Management Information Classification · 98% confidence The document is a press release dated January 10th, 2013, titled "Company reorganisation: governance adjustment." The content explicitly announces changes in the company's governance structure, specifically stating that senior management powers were entrusted to the Chairman and CEO, and detailing a new role for another individual. This directly aligns with the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2013-01-10 English
Developments in Malaysia : Announcement by METabolic EXplorer and Bio-XCell
M&A Activity Classification · 99% confidence The document is a press release dated January 2, 2013, detailing a development update regarding a construction project agreement between METabolic EXplorer and Bio-XCell in Malaysia. It discusses the completion of initial phases, ongoing discussions to amend the contract, and the partners' commitment. This type of announcement, which provides operational and strategic updates outside of standard periodic financial reports (like 10-K or IR), typically falls under general regulatory announcements or news releases. Since it is not a formal financial report, a specific financing event (CAP), a management change (MANG), or a legal update (LTR), the most appropriate general category for a corporate development announcement that doesn't fit elsewhere is Regulatory Filings (RNS), which serves as a broad category for miscellaneous regulatory news.
2013-01-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.